We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

Postgastrectomy Patients May Benefit From HP Eradication Rx

  • Shalmali Pal
  • Shalmali Pal
Dec 29, 2010
Volume: 
19
Issue: 
12

Study links gastric remnant cancer and Helicobacter pylori infection.

After resection for cancer or peptic ulcer disease, the mucosa of the gastric stump is considered prone to the development of gastric cancer precursor lesions (see Fact box), most likely because of exposure to Helicobacter pylori infection. Italian researchers set out to determine if the risk of gastric cancer recurrence was greater in the stump in the presence of HP infection.

For this study, Andrea Giuliani, MD, Luigi Basso, MD, and colleagues enrolled 187 patients who had received gastric resection for peptic duodenal ulcer (group 1) or advanced gastric cancer (group 2) and had gastric endoscopy years after the surgery. The investigators are from the department of surgery Pietro Valdoni at the University of Rome La Sapienza and the department of experimental medicine and pathology at the Policlinico Umberto I in Rome.

None of the patients had received eradication therapy for HP infection, antibiotics, nonsteroidal anti-inflammatory drugs, or chemotherapy in the month before gastric endoscopy. Up to a dozen biopsy specimens were routinely taken from the stoma and peristomal areas; from other areas of residual gastric mucosa along the lesser and greater curvatures; and from any areas showing erythema, erosion, or friability, the authors explained (Arch Surg 145:962-967, 2010).

According to the results, gastric cancer precursor lesions (GCPLs) were more common in the entire HP-positive population compared with the HP-negative patients (odds ratio [OR] 2.37, P = .007). In group 2, the HP-positive patients had a higher risk of GCPLs than the HP-negative patients (OR 4.20) and than all of the group 1 patients (OR 1.59).

Group 1 showed a prevalence of intestinal metaplasia, chronic nonatrophic gastritis (NAG), inflammation (P = .003), and HP infection (P = .05). In group 2, there was a prevalence of normal mucosa (P = .02) and dysplasia. The biopsy specimens showed that younger patients had a prevailing incidence of intestinal metaplasia while older patients had dysplasia and NAG (P = .04).

In group 1, a longer postoperative period before endoscopy corresponded to an increased incidence of normal mucosa and dysplasia while a shorter interval was linked to an increased incidence of chronic atrophic gastritis and inflammation. In group 2, a longer postoperative interval was related to multiple symptoms and HP infection. The occurrence of GCPLs was related to longer postoperative intervals, the authors stated.

The group concluded that HP positivity could indicate the expression of persistent or newly developed infection. "The risk of GCPLs, inflammation, and activity in HP-positive patients was notably increased compared with HP-negative patients," they wrote. "This is the most significant finding of our study and proves that there is a link between HP infection and gastric cancer carcinogenesis."

They strongly recommended that postgastrectomy patients undergo HP status assessment and possible HP eradication therapy after gastric resection.

 

FACT: Stomach cancer precursor

Cancer of the stomach is generally thought to develop from gastric cancer precursor lesions (GCPLs), including chronic atrophic gastritis, intestinal metaplasia, and dysplasia.

 

VANTAGE POINT

Research must look at mechanics of HP and malignant transformation

The associations between HP and subsequent gastric cancer made in this study are helpful, but the investigative community must dig deeper to identify the mechanism of action that leads to the development of gastric cancer after resection, wrote Dr. Behrns in an accompanying editorial. Dr. Behrns is the chair of the department of surgery at the University of Florida in Gainesville.

“Although the data suggest that patients with HP infection are indeed at risk for the development of premalignant lesions, it is also clearly evident that HP-negative patients were at significant risk for GCPLs,” Dr. Behrns said (Arch Surg 145:967, 2010).

The presence of HP infection does not appear to be solely responsible for the development of gastric cancer; another key element could be chronic inflammation, he said. As a result, “simple treatment for HP infection and/or a surveillance program clearly will not eliminate the development of gastric cancer in the remnant stomach.”

Dr. Behrns stressed that the surgical community must perform more hypothesis-driven, basic science studies in order to better understand the underlying mechanism of HP infection and chronic inflammation in this patient population.

 

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.